Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q1 FY23 Earnings Presentation
48 slides from Aster Dm Healthcare's earnings presentation, Aug 11, 2022
Slide 1: Cover letter to stock exchanges
August 11, 2022 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051
Slide 2: Investor Presentation for the quarter ended 30th June 2022
1 INVESTOR PRESENTATION For the quarter ended 30th June 2022
Slide 3: Disclaimer
2 Disclaimer • This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other cond
Slide 4: Vision
VISION A Caring Mission with a Global Vision to Serve the World with Accessible and Affordable Quality Healthcare.
Slide 5: Aster DM Healthcare – Evolution
Aster DM Healthcare – Evolution 4 New geographies, segments Brand “Aster” was formed, private Robust Growth across all Growth and Diversification into Building the foundations and service offerings equity investment, further expansion segments and geographies; Rapid aligned businesses across Expansi
Slide 6: Business Overview (Q1)
Business Overview (Q1) 5 One of the 29 GCC : 14 Largest Private Healthcare 5,293 GCC : 1,260 Hospitals India : 15 service providers operating Capacity Beds India : 4,033 in Asia (GCC & India) Presence in 7 Countries 121 GCC : 110 (UAE, Saudi Arabia, Qatar, Oman, 4.6 Mn GCC. : 3.9 Mn Clinics India :
Slide 7: Geographical Footprint
6 6 Geographical Footprint United Arab Emirates Kingdom of Saudi Arabia Kerala Andhra Pradesh Karnataka H(9) C(96) P(222) H(1) H(6) C(2) P(45) L(5) PEC(53) H(4) C(4) L(2) H(3) C(5) P(89) L(5) PEC(56) Oman Qatar Bahrain Jordan Maharashtra Telangana Tamil Nadu H(1) L(2) H(1) P(42) L(1) L(2) H(3) C(6)
Slide 8: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview 7 Note: 1. Revenue and EBITDA shown above excludes other income 2. Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated cor
Slide 9: GCC Hospitals
GCC Hospitals 88 UAE Oman Aster Hospital Mankhool Aster Hospital Qusais Cedars Hospital Al Raffah Ibri Hospital Al Raffah Dubai Dubai Dubai Hospital Ibri Hospital CB:136 OB:118 CB:158 OB:126 CB:20 OB:12 Muscat CB:31 OB:25 Sohar 2015, Leased 2018, Leased 2019, Leased CB:72 OB:52 2019, Leased CB:80 OB
Slide 10: India Hospitals
India Hospitals 99 Kerala Cluster Andhra & Telangana Cluster Karnataka & Maharashtra Cluster Aster Medcity Kochi, Kerala Dr Ramesh Main CB: 704 OB: 539 Centre 2014, Owned Aster CMI Vijayawada, AP Aster RV Hospital MIMS Kottakkal Bengaluru, CB:159 OB:135 Bengaluru, Kottakkal, Kerala Karnataka 2016, L
Slide 11: Hospitals: Pipeline Projects
Hospitals: Pipeline Projects 10 Owned / Hospitals - GCC Location Planned Beds Expected Completion Year Present Status Leased/O&M Aster Royal Hospital Muscat, Oman 145 Q2 FY 2023 Finishing Leased* Aster Hospital Doha, Qatar 60 Q4 FY 2024 Design Leased Owned / Hospitals - India Location Planned Beds E
Slide 12: The Aster DM Healthcare Edge
The Aster DM • Holistic healthcare solutions for people, 11 including primary, secondary, tertiary and quaternary care Healthcare Edge • 29 Hospitals equipped with state-of-the-art equipment Robust & • Extensive network of 121 clinics enabling • Revenue contribution by GCC and Indian Expansive patie
Slide 13: Historical Trends
12 Historical Trends Capacity Beds Outpatient Count (in mn) Inpatient Count (in ‘000) ..Coupled with capacity creation for further growth # of Units FY17 FY18 FY19 FY20 FY21 FY22 FY23 Q1 Hospitals 18 19 24 25 27 27 29 Clinics 96 101 114 117 115 120 121 Pharmacies - GCC 202 207 219 238 223 240 245 Ph
Slide 14: An Integrated Healthcare Provider
13 AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider
Slide 15: Aster - An Integrated Healthcare Provider
14 Aster - An Integrated Healthcare Provider FY22 Operational Information 1,500+ 273,000+ Cardiovascular IP Discharges Surgeries ~6.2 mn 20,500+ 1,300+ Clinic OPD Visits General Bariatric Surgeries Surgeries 2,400+ 800+ Joint ~ 8.0 mn Spine Replacements Pharmacy Surgeries Visits 13,600+ 500+ Urology
Slide 16: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem 15 Patient Life Cycle Management • Aster, over 35 years, Hospitals Clinics Pharmacies has created a Healthcare Ecosystem across two geographical regions • Indian operations act as a source of talent (Doctors, Nurses, and • In GCC region, other employees) Primary Care C
Slide 17: Digital Health
Digital Health 16 1Aster is ranked among the Top 10 Free Apps in Medical Category in the UAE in July 2022 Virtual Care- Omni-channel app for Patient interface Online Pharmacy Digital CRM ▪ In-app registration, appointments booking & ▪ Technology led approach with Omnichannel Fulfillment + ▪ Complex
Slide 18: Aster Labs
17 FOOTPRINT ORIGIN Having built strong presence PORTFOLIO in Karnataka & Kerala, Aster Aster Labs was established Labs has now expanded to in 2019, with one true With the latest technology Maharashtra, Tamil Nadu, preposition of providing and equipment, Aster Labs Telangana and Andhra THE TRUE TEST
Slide 19: Aster Pharmacy (India)
18 (INDIA) ◼ Initially to target 10 kms radius around Aster Hospitals in all cities for expansion. Current Status ◼ 176* stores launched across 3 states. ◼ Karnataka 89 stores Achieved the milestone of launching ◼ Kerala 45 stores 150 stores in a span of 15 months ◼ Telangana 42 stores Launched Firs
Slide 20: GCC Healthcare – Unique traits
GCC Healthcare – Unique traits 19 Healthcare market in GCC states, which is mostly insurance driven, have developed certain unique traits due to the higher expat and working age population Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) ➢ Due to lower % of older population
Slide 21: Aster - Awards & Service Excellence
Aster - Awards & Service Excellence 20 Dr. Azad Moopen • Alisha Moopen • Elected by World Economic Forum as a Young Chairman & Managing highest civilian award by the Government of India Deputy Managing Global Leader Director for being recognized across countries for his • Harvard Business Council In
Slide 22: Aster - Awards
Aster - Awards 21 Times All India Multispecialty Outlook's Best Hospital Ranking UAE Innovation Award Hospitals Ranking Survey 2021 2022 Aster Hospitals, UAE Aster Medcity, Aster CMI and Aster RV Aster Medcity & Aster CMI Dubai Quality Award IHF LinkedIn ranks Aster among Top 5 DQA - Medcare Hospita
Slide 23: Operational and Financial Overview
22 OPERATIONAL AND FINANCIAL OVERVIEW Operational and Financial Overview
Slide 24: Clinical Highlights - FY23 Q1
Clinical Highlights - FY23 Q1 23 India ➢ The Cardiothoracic & Vascular Surgery team of Aster Medcity implanted the first open heart suture less aortic valve - Perceval ( the first of its kind in Kerala) in a 55-year-old lady. The Perceval is a game-changer when it comes to the minimally invasive aor
Slide 25: Revenue and Profitability Snapshot – FY23 Q1
24 Revenue and Profitability Snapshot – FY23 Q1 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Revenue excluding new hospitals4 is Rs. ▪ EBITDA excluding new hospitals4 is Rs. ▪ PAT (Post-NCI) excluding new hospitals4 2,653 Crs. (Growth of 12 %) 312 Crs. (Growth of 11 %) and on
Slide 26: Geography – wise Financial – Snapshot – Quarterly
25 Geography – wise Financial – Snapshot – Quarterly GCC INDIA CONSOLIDATED FY22 Q1 FY23 Q1 Gw (%) FY22 Q1 FY23 Q1 Gw (%) FY22 Q1 FY23 Q1 Gw (%) Revenue (₹) 1,822 Cr 2,011 Cr 10% 550 Cr 651 Cr 18% 2,372 Cr 2,662 Cr 12% EBITDA (₹) 210 Cr 208 Cr -1% 71 Cr 84 Cr 18% 281 Cr 292 Cr 4% PAT (Post-NCI) (₹)
Slide 27: Geography – wise Business – Snapshot - Quarterly
Geography – wise Business – Snapshot - Quarterly 26 GCC INDIA CONSOLIDATED FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 Total Capacity Beds 1,151 1,260 3,757 4,033 4,908 5,293 Operational Beds (Census) 978 994 2,692 2,993 3,670 3,987 Operational Beds (Non-Census) 173 266 632 820 805 1,086 Availab
Slide 28: Geography – wise Business – Snapshot – Quarterly (India clusters)
Geography – wise Business – Snapshot – Quarterly 27 KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 Total Capacity Beds 1,894 2,153 967 1,009 896 871 3,757 4,033 Operational Beds (Census) 1,401 1,645 644 746 647 602 2,692 2,993
Slide 29: Segmental Performance FY23 Q1
28 Segmental Performance FY23 Q1 India - Labs Unallocated India - Labs Unallocated GCC GCC India - Hospitals GCC GCC India - Hospitals FY23 Q1 GCC Clinics & Wholesale & Total GCC Clinics & Wholesale & Total Hospitals Pharmacies & Clinics Hospitals Pharmacies & Clinics Pharmacy Eliminations Pharmacy
Slide 30: Maturity Wise Hospital Performance – GCC FY23 Q1
29 Maturity Wise Hospital Performance – GCC FY23 Q1 Key Performance indicators Revenue Operational Beds EBITDA Maturity Hospitals (INR in Crs.) (Census) EBITDA % ARPOBD Occupancy (INR in Crs.) 2% 11% ₹(16) 0-3 Years 3 ₹ ~311,300 8% NM ₹18 112 Over 3 98% 89% ₹148 11 ₹ ~192,700 55% 16.6% Years ₹895 88
Slide 31: Maturity Wise Hospital Performance – India FY23 Q1
Maturity Wise Hospital Performance – India FY23 Q1 30 Key Performance indicators Revenue Operational Beds EBITDA Maturity Hospitals (INR in Crs.) (Census) EBITDA % ARPOBD Occupancy (INR in Crs.) 2% 4% ₹(5) 0-3 Years 2 ₹ ~28,600 39% ₹10 117 NM Over 3 98% 96% ₹104 12 ₹ ~36,450 64% 17.1% Years ₹606 2,8
Slide 32: Financial Summary – Profitability Statement
31 Financial Summary – Profitability Statement As at Mar 31, As at Jun 30, Particulars (INR Cr) FY22 Q4 FY22 Q1 FY23 Q1 Y-o-Y Gw% Q-o-Q Gw% India (in INR Cr) 2022 2022 Revenue from operations 2,728 2,372 2,662 12% -2% Gross Debt 431 439 Less: Cash, Bank Balance and Current Investments 112 81 Materia
Slide 33: Consol Trends - I
32 Consol Trends - I Revenue (INR Cr) EBITDA EBITDA Margin ROCE EBITDA numbers are Post IndAS116 FY21 numbers have an impact of COVID
Slide 34: Consol Trends - II
33 Consol Trends - II Net Debt (excl. Lease Liabilities) (INR Cr) Net Debt (incl. Lease Liabilities) (INR Cr) Net Debt (excl. Lease Liabilities)/EBITDA Net Debt (incl. Lease Liabilities)/EBITDA* * Post IndAS 116 FY21 numbers have an impact of COVID
Slide 35: India: Financial Trends
India: Financial Trends 34 Revenue EBITDA EBITDA Margin ROCE
Slide 36: India Hospital & Clinics Cluster-Wise Trends
India Hospital & Clinics Cluster-Wise Trends 35 Kerala Cluster Karnataka & Maharashtra Cluster Andhra & Telangana Cluster Revenue (INR Cr) Revenue (INR Cr) Revenue (INR Cr) EBITDA (INR Cr) EBITDA (INR Cr) EBITDA (INR Cr) EBITDA Margin EBITDA Margin EBITDA Margin The EBITDAR for K&M cluster for FY 23
Slide 37: Strategy & Leadership
36 STRATEGY & LEADERSHIP Strategy & Leadership
Slide 38: GCC Strategy
37 Strengthening of our medical tourism network GCC Strategy • To further strengthen integration of GCC & India operations to provide consistent quality experience The pandemic allowed us to reflect and re- to patients across geographies invent certain processes at all the locations. • To position o
Slide 39: India Strategy
38 In line with India Strategy Aster DM Healthcare focus on hopes to leverage its derisking Focus on extensive experience business large format of working in a 100% target of 40%- hospitals in Tier 1 insurance market in 50% of overall cities Hospitals the GCC to derive revenues in the in Tier 1 citi
Slide 40: ESG: Committed to UN Sustainable Development Goals
39 ESG: Committed to UN Sustainable Development Goals
Slide 41: Aster’s ESG Materiality Assessment
40 40 Economic Social Environment GRI 201: Economic GRI 413: Local GRI 302: Energy Performance communities GRI 303: Water Aster’s GRI 405: Diversity and equal opportunity GRI 306: Effluent and Waste ESG Materiality Assessment GRI 404: Training and education GRI 305: Emissions GRI 307: GRI 403: Occup
Slide 42: Aster’s commitment to UNSDG
41 Aster’s commitment The 17 Sustainable Development Goals are considered as the blueprint to achieve a sustainable future for all, it is important that we all work together to achieve them by to UNSDG 2030. At Aster, we have identified the goals relevant to our operations, and we are working toward
Slide 43: Aster’s alignment with SASB to focus on material issues
42 Aster’s alignment with SASB to focus on material issues Dimension Issue Efficient utilization of energy Optimizing water use Environment Climate Care Embracing circular economy Our people- Health and Safety, engagement, Diversity and Inclusion Volunteering program Response to COVID-19 Social Pati
Slide 44: Aster DM Healthcare - ESG update
43 Aster DM Healthcare - ESG update Environment Social Governance • Embedded Environmental parameters (energy • Code of Conduct policy is available and • The criteria for conducting the performance emission, water and biodiversity under CSR policy) committed to providing employees with a safe evalua
Slide 45: Aster – ESG Strategy
44 44 Aster – ESG Strategy Current ESG practices External engagement for gap ESG Policy and ESG Risk ESG Pillars identified in assessment of Aster’s framework approved by the Board level ESG commitment Sustainability Report Aster Board sustainability report against global frameworks Next steps • • F
Slide 46: Aster Leadership Team
Aster Leadership Team 45 Dr. Azad Moopen Founder, Chairman & Managing Director T. J. Wilson Fara Siddiqi Alisha Moopen Sreenath Reddy Group Head - Governance & Group Chief Human Deputy Managing Director Corporate Affairs, GCC Group Chief Financial Officer Resources Officer Dr. Malathi Veneeth Purush
Slide 47: Aster Board of Directors
Aster Board of Directors 46 Dr. Azad Moopen Alisha Moopen T. J. Wilson Anoop Moopen Chairman and Managing Deputy Non-Executive Director Non-Executive Director Managing Director Director Shamsudheen Bin Daniel Robert Prof. Biju Varkkey Sridar Arvamudhan Mohideen Mammu Haji Mintz Iyengar Independent D
Slide 48: Thank You
47 Thank You www.asterdmhealthcare.com Email: investors@asterdmhealthcare.com